Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuki Yasuda

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 23, 2005
[PPARgamma gene Pro12Ala polymorphism in diabetes mellitus]Kazuki Yasuda
Journal of Diabetes Investigation|July 7, 2018
Bariatric and metabolic surgery in Asia: Where are we, and where are we going?Kazuki Yasuda
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 14, 2011
[Genetic factors for diabetic microvascular complications]Kazuki Yasuda
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 18, 2010
[PPARG gene polymorphism and disease susceptibility]Kazuki Yasuda
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 21, 2016
[The 43rd Scientific Meeting: Perspectives of Internal Medicine; Genetic predisposition and related life-style underlying metabolic disorders: 2. Genetic and Environmental Susceptibility; 1) The predisposition to impaired glucose metabolism]Kazuki Yasuda
Diabetologia|December 16, 2014
MafA is critical for maintenance of the mature beta cell phenotype in miceWataru Nishimura, Satoru Takahashi, Kazuki Yasuda
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2002
[MODY genes]Terumasa Okada, Yuzuru Ito, Kazuki Yasuda
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 3, 2002
[Systematic hunt for diabetes candidate genes]Yuzuru Ito, Terumasa Okada, Kazuki Yasuda
The Journal of Clinical Endocrinology and Metabolism|February 22, 2025
Consistently low serum levels of MG-H1 is associated with a lower risk of diabetic kidney diseaseTomoka Nakamura, Tetsuro Tsujimoto, Kazuki Yasuda, et al.
Cardiovascular Diabetology|June 23, 2023
Continuous low serum levels of advanced glycation end products and low risk of cardiovascular disease in patients with poorly controlled type 2 diabetesTomoka Nakamura, Tetsuro Tsujimoto, Kazuki Yasuda, et al.
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 23, 2005
[PPARgamma gene Pro12Ala polymorphism in diabetes mellitus]Kazuki Yasuda
Journal of Diabetes Investigation|July 7, 2018
Bariatric and metabolic surgery in Asia: Where are we, and where are we going?Kazuki Yasuda
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 14, 2011
[Genetic factors for diabetic microvascular complications]Kazuki Yasuda
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 18, 2010
[PPARG gene polymorphism and disease susceptibility]Kazuki Yasuda
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 21, 2016
[The 43rd Scientific Meeting: Perspectives of Internal Medicine; Genetic predisposition and related life-style underlying metabolic disorders: 2. Genetic and Environmental Susceptibility; 1) The predisposition to impaired glucose metabolism]Kazuki Yasuda
Diabetologia|December 16, 2014
MafA is critical for maintenance of the mature beta cell phenotype in miceWataru Nishimura, Satoru Takahashi, Kazuki Yasuda
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2002
[MODY genes]Terumasa Okada, Yuzuru Ito, Kazuki Yasuda
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 3, 2002
[Systematic hunt for diabetes candidate genes]Yuzuru Ito, Terumasa Okada, Kazuki Yasuda
The Journal of Clinical Endocrinology and Metabolism|February 22, 2025
Consistently low serum levels of MG-H1 is associated with a lower risk of diabetic kidney diseaseTomoka Nakamura, Tetsuro Tsujimoto, Kazuki Yasuda, et al.
Cardiovascular Diabetology|June 23, 2023
Continuous low serum levels of advanced glycation end products and low risk of cardiovascular disease in patients with poorly controlled type 2 diabetesTomoka Nakamura, Tetsuro Tsujimoto, Kazuki Yasuda, et al.
Pageof 14